Press Release: Ovid Therapeutics and Ligand Pharmaceuticals Enter Into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway Into 2026
Press Release: Ovid Therapeutics and Ligand Pharmaceuticals Enter Into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway Into 2026
新聞稿：Ovid Therapeutics和Ligand Pharmicals簽訂了一項3000萬美元的協議，收購Soticlestat特許權使用費的13％權益，里程碑將Ovid的現金跑道延長至2026年
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊